• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

New Open Source Project Enlists Students To Find Cures For Neglected Diseases

03/05/2017 by Intellectual Property Watch 1 Comment

The Drugs for Neglected Diseases initiative (DNDi) has launched a collaborative project with five universities in India, United Kingdom, and the United States to help with the research on a debilitating neglected disease.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Health & IP, Innovation/ R&D, Other International Orgs, Patents/Designs/Trade Secrets

WTO IP Division Director’s Thoughts On World IP Day

26/04/2017 by William New, Intellectual Property Watch 1 Comment

Antony Taubman, director of the World Trade Organization Intellectual Property Division, has been in a good position to view the world and intellectual property for some time. Today, designated as World IP Day, we caught up with him to ask his views on the theme this year.

Filed Under: IP Policies, Language, Themes, Venues, Copyright Policy, English, Innovation/ R&D, Patents/Designs/Trade Secrets, Trademarks/Geographical Indications/Domains, WTO/TRIPS

US Government Intends To Grant Exclusive Licence On Zika Patent Over Objection Of Civil Society

26/04/2017 by Intellectual Property Watch 1 Comment

The United States Department of Defense has announced that it intends to grant Sanofi Pasteur, a French pharmaceutical corporation, exclusive rights to develop a vaccine for the Zika virus. The decision follows outcry from the public and civil society groups over concerns of affordability and accessibility in taking such a step.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Finance, Health & IP, Human Rights, Innovation/ R&D, North America, Patents/Designs/Trade Secrets, Regional Policy

Winners Of Ideas4Change For UN Sustainable Development Goals

26/04/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment

Inventions to contribute to the 2030 United Nations Sustainable Development Goals have been rewarded. A reactor which converts carbon dioxide into ethanol, a method for the detection of pesticides and contaminants in food, and renewable leather created from bacteria won the heart of the jury.

Filed Under: IP Policies, Language, Themes, Venues, Copyright Policy, Development, English, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, Trademarks/Geographical Indications/Domains, United Nations - other

‘Make Sure The Trademark Lawyer Is There’ At The Beginning

26/04/2017 by Peter Kenny for Intellectual Property Watch Leave a Comment

For World Intellectual Property Day this year, the World Intellectual Property Organization held a discussion on “Innovation in Communication: A State of Mind,” with a creator designer, a brand consultant and a writer as the panel.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, English, Information and Communications Technology/ Broadcasting, Innovation/ R&D, Lobbying, Trademarks/Geographical Indications/Domains, WIPO

Internet Of Things Is The Next Big Thing In Patents, And EPO Says It’s Ready For It

21/04/2017 by Dugie Standeford for Intellectual Property Watch 2 Comments

The European Patent Office has a “tradition of looking forwards” to anticipate patenting trends, and it sees the Internet of Things (IoT) as the next challenge, Chief Economist Yann Ménière said at 20 April OxFirst webinar on the office’s contribution to the coming world of billions of connected objects.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, English, Europe, Innovation/ R&D, Patents/Designs/Trade Secrets, Regional Policy

Tech, Auto Companies Urge US Action On Standard Essential Patents

21/04/2017 by Intellectual Property Watch Leave a Comment

A group of 15 US and foreign tech and automobile companies and organisations has sent a letter to the White House asking for support to reduce what they see as rising anti-competitive licensing practices involving standards essential patents (SEPs).

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Finance, Innovation/ R&D, North America, Patents/Designs/Trade Secrets, Regional Policy

Neglected Tropical Diseases: Gates Celebrates Industry Contribution, Chan Concurs

19/04/2017 by Catherine Saez, Intellectual Property Watch 1 Comment

Five years after health institutions and actors including pharmaceutical companies endorsed the London Declaration on Neglected Tropical Diseases, meant to support the World Health Organization to control and eradicate 10 specific diseases by 2020, new commitments were announced today (18 April) in Geneva.

Filed Under: IP Policies, Themes, Venues, English, Finance, Health & IP, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, WHO

Google’s Waymo v. Uber Lawsuit Reflects High-Stakes IP War In Hot Driverless Car Sector

17/04/2017 by Bruce Gain for Intellectual Property Watch 2 Comments

Google’s Waymo claims Uber, an app-based taxi service, stole technology for a critical component for driverless cars, as the one of the world’s most-powerful tech titans wages a fierce legal battle to protect its intellectual property in an emerging area of the automotive industry.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, Enforcement, English, IP Law, Innovation/ R&D, North America, Patents/Designs/Trade Secrets, Regional Policy

The Deepening Debate Over Vaccines And Antimicrobial Resistance Involves IP

12/04/2017 by Tatum Anderson for Intellectual Property Watch 1 Comment

With the looming threat of antimicrobial resistance (AMR), there is growing pressure to use vaccines because they obviate the need to prescribe antibiotics in the first place.

Filed Under: IP Policies, Subscribers, Themes, Venues, English, Europe, Finance, Health & IP, Innovation/ R&D, Other International Orgs, Patents/Designs/Trade Secrets, Regional Policy

  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 228
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2026 · Global Policy Reporting